Synopsys (Synopsys) Total Liabilities

: $3,852 Mil (As of Jan. 2024)

View and export this data going back to 1992. Start your Free Trial

Synopsys's Total Liabilities for the quarter that ended in Jan. 2024 was $3,852 Mil.

Synopsys's quarterly Total Liabilities increased from Jul. 2023 ($3,923.35 Mil) to Oct. 2023 ($4,148.83 Mil) but then declined from Oct. 2023 ($4,148.83 Mil) to Jan. 2024 ($3,851.64 Mil).

Synopsys's annual Total Liabilities increased from Oct. 2021 ($3,453.32 Mil) to Oct. 2022 ($3,858.90 Mil) and increased from Oct. 2022 ($3,858.90 Mil) to Oct. 2023 ($4,148.83 Mil).

Synopsys Total Liabilities Historical Data

The historical data trend for Synopsys's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Liabilities

Get a 7-Day Free Trial

2,316.28

3,117.70

3,453.32

3,858.90

4,148.83

Synopsys Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															3,886.87	3,917.91	3,923.35	4,148.83	3,851.64

Synopsys Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Synopsys's Total Liabilities for the fiscal year that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2985.451	+	(602.113	+	85.407
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	475.859	+	0)
	=	4,149

Total Liabilities	=	Total Assets (A: Oct. 2023 )	-	Total Equity (A: Oct. 2023 )
	=	10333.131	-	6184.301
	=	4,149

Synopsys's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2644.507	+	(580.766	+	87.525
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	538.844	+	0)
	=	3,852

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	10558.259	-	6706.617
	=	3,852

Synopsys Total Liabilities Related Terms

Thank you for viewing the detailed overview of Synopsys's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Synopsys (Synopsys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SNPS:Mexico SYPd:UK SYP:Germany SYP:Germany SYP:Germany S1NP34:Brazil

Address

675 Almanor Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.synopsys.com

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Executives

Mercedes Johnson	director	MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney	officer: Chief Revenue Officer	2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr	officer: General Counsel &	C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi	officer: VP and Corporate Controller	690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter	director	C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De	director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi	officer: Chief Operating Officer	3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser	officer: CFO	ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee	director	2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan	officer: EVP, Sales & Corp Marketing	700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias	director	UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham	officer: CFO	700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen	director	58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper	director	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan	director, officer: Co-CEO & President